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5.    ABBREVIATIONS  
 
AA Arcuate artery 
AORTA  Infrarenal Aorta  
ATA Anterior tibial artery 
CFA Common femoral artery 
CIA Common iliac artery  
CLI Critical limb ischemia  
DM Diabetes Mellitus  
DP Dorsalis pedis  
DSA  Digital subtraction angiography 
DYS Dyslipidemia  
EIA  External iliac artery  
EXSMOK Ex-smoker 
F Female  
FEM-POP Femoropopliteal segment 
HPT Hypertension  
IIA Internal iliac artery 
LPA  Lateral plantar artery 
M Male  
MPA Medial plantar artery 
N0 Null hypothesis  
PAD  Peripheral arterial disease 
PASS Power Analysis and Sample Size 
PER Peroneal artery 
PFA Profunda femoris artery 
POP Popliteal artery  
PTA Posterior tibial artery 
SFA  Superficial femoral artery  
SMOK Smoker 
TIBIO-PER Tibioperoneal segment 











6.   DEFINITION OF TERMS  
 
Major Risk Factor Combination  groups   
  Group 1 DM, HPT, Dyslipidemia 
Group 2 DM, HPT, dyslipidemia, ex-smoker 
Group 3 DM, HPT, dyslipidemia, smoker 
 
 
 Ex-smoker           
 
Stopped smoking for a period of more than 
three months without relapse. 
  
Patency grading system 
  
Category 1 
Widely patent (Angiographic image  with 
clean pristine edges) 
Category 2 
Diffusely diseased but patent (Shaggy 
edges but no obvious stenosis) 
Category 3 
Haemodynamically insignificant occlusive 
lesions (Areas with <50% stenosis) 
Category 4 
Haemodynamically significant occlusive 
lesions (Areas with ≥ 50 % stenosis) 








The anastomosis between the lateral plantar 
and the dorsalis pedis is intact filling the 
metatarsal and digital arteries 
Incomplete 
The anastomosis between the two arteries is 
not observed 
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9.  ABSTRACT 
 
Background The literature tends to support the notion that diabetic patients typically suffer from tibio-
peroneal artery occlusive disease (1) (2) (11) (5) (10) (8) with relative sparing of the foot arteries (1). This  study 
seeks to  investigate the pattern and distribution of peripheral artery occlusive disease and the arterial foot 
arch status in diabetic patients with critical limb ischaemia 
 
Methods: This is a one year prospective study -(January 2014 to December 2014) carried out on consecutive 
patients seen at Groote Schuur Hospital, Vascular Department. The inclusion criteria is: diabetic patients  ≥18  
years of age with critical limb ischemia who  had pre- and post-intervention vascular imaging. The calculated 
minimum sample size of 63 limbs [756 patency levels (63x12)] was needed to achieve a power of 86% to detect 
a difference of 0.1900 (19%) with a target significance level of 0.05 (using PASS 11 software). The equality of 
distribution of categories was analyzed using the One sample Chi-square test (SPSS 22) with our Null 
hypothesis (N0)  assuming that categories occur with equal proportions. In this case categories refers to the 5 
patency levels used in this study. All 12 main arteries from infra-renal aorta to crural arteries had their patency 
levels graded from category 1 to category 5 (widely patent to occluded). The findings were then stratified 
according to gender, age group ( <40 years, 40-54 years and ≥ 55 years) and risk factor combinations [ Group1 
= (DM, HPT, Dyslipidemia); Group 2= (DM, HPT, dyslipidemia, exsmoker); Group 3 = (DM, HPT, dyslipidemia, 
smoker)]. The three risk combination groups formed the majority of our study group (79%).  
 
Results: Seventy-one patients were analyzed: 38/71 females and 33/71 males. Eight hundred and twenty (820) 
patency categories were recorded [8 patients did not have their aorto-iliac segment imaged (8x4=32)]. There 
were relatively more category 5 and category 4 (occlusions and high grade- stenosis) patency levels in the 
tibioperoneal segment with statistically significant disproportion (P <.001 for both categories). However it is 
worth noting that females had relatively less severe grades of occlusive disease proximally compared to males 
(females recorded no occlusions in the aortoiliac segment vs 6 recorded for males) . Group 3 have a different 
distribution pattern, with a disproportionate distribution of occlusions (P<0.001) with more occlusions in the 
femoropopliteal segment followed by tibioperoneal segment. Group 1  and group 2 had disproportionately 
more occlusions to distal segment (P<0.001). Patients  over the age of 55 also had disproportionately more 
occlusions distally (P<0.001). The majority of our patients are within this age group. Only 10/71 patients had an 
absent foot arch; 28/71 patients  had an incomplete foot arch; 31/71 had a complete foot  arch and 2/71 had a 
poorly imaged foot arch. There was a statistically significant disproportionate distribution (P = 0.004) with the 
majority of patients having a complete foot arch (Fig 1.12). However on stratifying patients according to 
gender it became clear that it is female diabetic patients  who predominantly had a complete foot arches 
(22/37;59%) (P=0.004). Male  patients  predominantly had an incomplete arch (17/32;53% (P =0.048)). Group 2 
patients  had predominantly complete foot arches 9/13 . For group 1 and group 3  the proportions in the 
arterial arch status categories were almost the same with slight predominance of incomplete foot arch, 
followed by complete arch (P<0.05)- Fig 1.15. 
 
Conclusion: Diabetic patients in general  have severe tibio-peroneal disease. Gender and patients 
older than 40 years have the same disproportionate distribution of severe lesions to distal segments. 
However female patients have less severe disease. Group 3 patients  have a disproportionate 
distribution of occlusions (P<0.001) with more occlusions in the femoropopliteal segment.  Group 1 
and group 2 had a disproportionate distribution of occlusions(category 5) to distal segment (P<0.001). 
Female diabetics tends to have a complete arterial foot arch (P=0.004) as opposed to male patients 
who have predominantly incomplete foot  arches (P=0.048). Group 2 have predominantly complete 
arterial foot arch while group 1 and group 3 predominantly have an incomplete arterial foot arch.  The 






10.  INTRODUCTION  
 
The literature tends to support the notion that diabetic patients 
typically suffer from tibio-peroneal artery occlusive disease (1) (2) 
(11) (5) (10) (8) with relative sparing of the foot arteries (1). A 
few studies dispute this notion of severe distal segment 
involvement in diabetic patients (3) and the arterial foot arch 
sparing (3) (2). These observations have enormous implications 
relating to revascularization procedures, bypass graft patencies, 
limb salvage,  healing of ischaemic foot lesions and, to a lesser 
extent, feasibility of pedal artery bypass procedures when 
indicated. Studies have looked at the impact of quality of the 
arterial foot arch and the angiosome revascularization on below 
knee bypass outcomes as well as foot ulcer healing rate(17)(18). 
The findings were statistically significant association between rate 
of foot ulcer healing and quality of the arterial foot arch (17)(18). 
The predominant impression from the literature review is that 
there is no association between the quality of the arterial foot 
arch and the amputation free survival or graft patency rates. It is 
relevant to stratify diabetic patients according to their risk factor 
profile, age group and gender when assessing the pattern and 
distribution of peripheral arterial occlusive disease (PAD). This 
study set out to investigate the pattern and distribution of 
peripheral artery occlusive disease and the arterial foot arch 
status in diabetic patients with critical limb ischaemia. The 
findings were then stratified according to:  
 Gender. 
 Age group (<40 years, 40-54 years and ≥ 55 years).  
 Risk factor profile (diabetes, hypertension, dyslipidemia, 
smoking, ex-smoker). 
 
11.  AIM 
The aim of this study is to study the pattern and distribution of 
Peripheral arterial disease in diabetic patients with critical limb 
Ischemia Rutherford category 4 – 6  and to stratify the pattern 
and distribution according to their atherosclerosis risk factor 




LITERATURE REVIEW  
PERIPHERAL ARTERIAL DISEASE:  
Overview  
Peripheral artery occlusive disease, also commonly known as 
peripheral artery disease (PAD) is characterized by occlusive 
atherosclerotic disease of peripheral arteries. It causes  significant 
morbidity and mortality. It is a global challenge and consumes a 
lot of resources. The impact of PAD is more in the lower 
extremities. Its management is a constant challenge to the 
vascular surgeons.  The worldwide prevalence of this disease still 
remains unclear. In the USA  it is estimated that 8 to 12 million 
people are affected by PAD(33). PAD is clearly more prevalent in 
the elderly population. It is a progressive disease with a clinical a 
picture ranging from asymptomatic to symptomatic. The majority 
of patients have a subclinical disease (asymptomatic).  
PAD is associated with shortened survival mainly due to its 
systemic effects on multiple organs ( heart, brain, kidneys etc.). 
Epidemiology  
The worldwide prevalence of  peripheral artery occlusive disease 
remains unclear. The prevalence in the USA is estimated at 8 to 
12 million (32).PAD is less common in women than it is in 
men(36). It occurs earlier in men than in women(35). It is more 
prevalent in the aging populations. A recent systematic review of 
34 studies  looked at “Comparison of global estimates of 
prevalence and risk factors for peripheral artery disease in 2000 
and 2010: a systematic review and analysis”(33). The following 
were the findings: 
 Globally there were  202 million people in 2010 with PAD. Of 
these  
o 69·7% were in the low-income or middle-income 
countries: prevalence in southeast Asia being 54·8 
million and western Pacific Region having a prevalence 
of  45·9 million in the.  
 There was an increase in prevalence of  PAD during the 
preceding decade by 28·7% in low-income or middle-income 
countries and 13·1% in high-income countries. 





The arterial atherogenesis is a complex process that is driven by 
an interaction between different processes some of which are 
poorly understood. The evolution of the atherosclerotic plaque 
follows a response to an injury to the normal vascular endothelial 
cells culminating in formation of a thrombus and ultimately 
angiogenesis and neovascularization. The atherosclerotic plaque 
thus formed can be: 
1. Unstable (high-risk) plaque:  which is associated with a 
high risk of rupture and distal embolization causing acute 
embolic events or  acute intraluminal thrombosis leading to 
arterial occlusion. It has a thin fibrous cap.  
2. Stable plaque: It has a stable fibrous cap. It is not 
ulcerated and therefore is less likely to rupture and cause 
embolic events or acute occlusion of the artery by 
intraluminal thrombosis. However it still has the potential to 
progress to symptomatic disease.  
 
 






The atherosclerosis risk factors can be grouped into modifiable 
and non-modifiable risk factors.  
Four main modifiable conventional atherosclerotic risk factors are:  
 hypertension, 
 hypercholesterolemia,  
 diabetes,  
 smoking.  




 Family history 
Very often one of these risk factors are present at the time of 
diagnosis of peripheral arterial disease. Age is a major non-
modifiable risk factor. Risk factor modification is a key component 
of PAD management(34)(35). 
The results of a  study published in 2004(45) looking at the 
association of risk factors with PAD using logistic regression 
analysis is summarized in the table below: 
 
 
Table 1.a Odds ratio for risk factor association with PAD. 
These are compelling results and it is highly unlikely such  




Risk factors  OR (Association with 
PAD) 
Black race  2.83 
Current smoking  4.46 
Diabetes  2.71 
hypertension 1.75 
Hypercholesterolemia  1.68 




The most commonly used screening test is resting ABI (34)(35). 
It is easy to do, cheap, more acceptable to patients and safe.  
The ABI calculation: (systolic blood pressure at the 
ankle)/(brachial artery systolic blood pressure obtained while 
patient is lying down) 
Interpretation: ABI <1 (usually quoted as <0.9) is considered 
abnormal and usually used to diagnose PAD. 
There is no evidence showing benefit in ABI screening of 
asymptomatic patients(36)(37). A recent(2013) literature review 
by USPSTF (U.S. Preventive Services Task Force) concluded 
that there is insufficient evidence to assess the benefit of 
screening adults with ABI.  
It is worth mentioning that ABI as a screening tool has its 
shortcomings in diabetic patients mainly because the calcified 
arteries lead to falsely normal or elevated Doppler pressures in 
this group of patients (46).   
Natural history of PAD: 
The understanding of  progression of PAD from the asymptomatic 
(but having an abnormal ABI) to symptomatic disease is key for 
managing these group of patients. The literature shows that when 
asymptomatic patients are followed over a period of five years, 7-
15% of them will develop symptoms. This was consistently found 
in two studies(38)(39). Patient with asymptomatic PAD are still at 
risk of developing other atherosclerosis associated events. 
Symptomatic PAD  
Symptomatic patients can present as intermittent claudication, 
critical limb ischemia or may present as an acute limb ischemia.  
Critical limb ischemia: “The European Consensus defines 
critical limb ischemia  as rest pain for more than two 
weeks, or ulceration/gangrene, and an ankle pressure 
of <50 mmHg or a toe pressure of <30 mmHg”. 
Acute limb ischemia “The revised (2007) TASC Inter-
Society Consensus defines acute leg ischaemia (ALI) as 
any sudden decrease in limb perfusion causing a 
potential threat to limb viability” 
There are two main classifications of PAD based on its severity: 
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 Fontaine classification 
 Rutherford classification 
Table 1.b Fontaine classification of PAD severity  
Grade  Category  Description 
0 0 Asymptomatic  
I 1 Mild claudication 
I 2 Moderate 
claudication  
I 3 Severe claudication  
II 4 Ischemic rest pain  
II 5 Minor tissue loss  
III 6 Major tissue loss  
Table 1.c Rutherford classification of PAD Severity 
Follow-up studies have shown that half of the claudicants remain 
stable (no deterioration of symptomatology) at 5 years or 
improve. One quarter of the claudicants will experience 
deterioration in walking distance over 5 years(40). About 5% of 
those who will experience deterioration in walking distance will 
experience worsening of symptoms severe enough to require 
revascularization and about 1% of them will end up with an 
amputation(41). 
The overall outcome in patients with critical limb ischemia is very 
poor. 
Diagnostic Test  
The diagnostic test according to ACCF/AHA Practice Guidelines: 
“2011 Updated Recommendation: The resting ABI should be 
used to establish the lower extremity PAD diagnosis in patients 
with suspected lower extremity PAD, defined as individuals with 1 
or more of the following: 
 exertional leg symptoms,  
Fontaine stage Description 
I Asymptomatic  PAD but no symptoms  
II Intermittent 
claudication  
Cramping pain on lower limb 
muscles precipitated by walking 
and relieved by rest 
III Rest pain  Constant feet pain (commonly 
worse at night) 
IV Tissue loss Ischemic ulcer of gangrene 
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 non-healing wounds,  
 age 65 and older, or 50 years and older with a history of 
smoking or diabetes. (Level of Evidence: 1B) 
Pulse volume recordings are reasonable to establish the initial 
lower extremity PAD diagnosis, assess localization and severity, 
and follow the status of lower extremity revascularization 
procedures. (Level of Evidence: 2B) 
Continuous-wave Doppler ultrasound blood flow 
measurements are useful to provide an accurate assessment of 
lower extremity PAD location and severity, to follow lower 
extremity PAD progression, and to provide quantitative follow-up 
after revascularization procedures.(Level of Evidence: 1B) 
Treadmill Exercise Testing With and Without ABI Assessments and 
6-Minute Walk Test 
Duplex ultrasound of the extremities is useful to diagnose 
anatomic location and degree of stenosis of PAD.(Level of 
Evidence:1A) 
Contrast Angiography: Contrast angiography provides detailed 
information about arterial anatomy and is recommended 
for evaluation of patients with lower extremity PAD when 
revascularization is contemplated. (Level of Evidence: 1B).” 
 
Treatment of PAD 
Treatment of PAD disease requires a multidisciplinary approach. 
Below are a list of components of the management scheme for 
patients with PAD. 
 Cardiovascular Risk Reduction 
o Lipid-Lowering Drugs 
o Antihypertensive Drugs 
o Diabetes Therapies 
o Smoking Cessation 
o Antiplatelet and Antithrombotic Drugs 
 Exercise and Lower Extremity PAD Rehabilitation 
 Endovascular Treatment for Claudication 
 Surgery for Claudication (Open surgery) 
 
Outcomes of PAD 
It is estimated that  of claudicants:   
 Approximately 50%  will have symptomatic  improvement 
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 25% will remain stable  
 25% will have symptomatic deterioration  
 5% will need revascularization   
 1-2%  will require ablative therapy in the form of major 
amputation 
 50% of claudicants will be dead during 10 years follow-up. 
Of every 100 claudicants 1 will progress to critical limb ischemia 
For patient with critical limb ischemia  
 20-25% of patients will die within a year of follow up. 
 Half of them will be dead at 5 years of follow up.  
 
CRITICAL LIMB ISCHEMIA IN DIABETIC PATIENTS :  
Overview   
Diabetes is one of the main risk factors of developing PAD. The 
global prevalence of diabetes is estimated at 366 million people. 
Peripheral arterial disease is a known cause of morbidity and 
mortality in diabetic patients worldwide. It is a problem that needs 
well-coordinated multidisciplinary approach (43) to manage. 
Some studies have shown a higher risk of PAD in Hispanic 
American and African American with diabetes(44).The systemic 
impact of atherosclerosis in is more pronounced in diabetic 
patients. 
Pattern and distribution of PAD in DM patients  
With the advent of DSA observant researchers noted a unique 
pattern and distribution of occlusive arterial disease in diabetic 
patients with critical limb ischemia. The impression they got was 
that diabetic patients had more occlusions in their distal arterial 
segments compared to nondiabetic patients (1)(2)(5)(11). 
Karacagil S. et al (1) also noted an association between severe 
involvement of the foot arteries and severe involvement of 
tibioperoneal arteries. In his study published in 1989  he observed 
tibioperoneal occlusions in 71% of the diabetic patients compared 
to  52% of the non-diabetic patients . Peroneal artery was less 
frequent involved. He divided the arterial  foot arch into the 
posterior and anterior arches and found that the posterior arterial 
foot arch was more often preserved than the anterior foot arch 
(1). Four years later (1993) two studies were published (2)(3), 
Ciavarella A. and his colleagues also found that diabetics had 
severely involved tibioperoneal segment but  disagreed with the 
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suggestion that diabetics had a relatively spared arterial foot arch 
(2). Hilfiker M. and his colleagues (3) found no statistically 
significant difference between diabetics and non-diabetic patients 
concerning the pattern and distribution of PAD as well as 
involvement of the  arterial foot arch. Some studies  noted that 
non-diabetic patients had more pronounced involvement of  
aortoiliac and femoropopliteal segments than diabetic patients 
(2).  
 
Pattern and distribution of PAD in DM patients according to 
their risk factor combinations 
 Towards the end of the century the questions addressed by 
researchers were shifting from those of pattern and distribution of 
arterial disease in diabetic versus non‐diabetic patients to those of 
pattern and distribution according to risk factor profile. Among the 
first publications to address this question were Karacagil S. and 
colleagues 1996(5): looking at normotensive vs hypertensive in 
diabetics and non‐diabetics. The occlusion rate was higher in 
diabetic patients (both hypertensives and normotensives) relative 
to non‐diabetics (hypertensives 77% vs 56% ; normotensives 
73% vs 51% respectively). Concerning the arterial foot arch they 
found that the incidence of having both foot arches intact was 
significantly higher in nondiabetic patients with  hypertension. The 
conclusion therefore was that hypertension does not seem to 
contribute to the extent and severity of lower leg and foot vessel 
involvement. N. Diehm and his colleagues in 2006(10) 
investigated the risk factor profile association with pattern and 
distribution of PAD in 2659 patients. The following were their 
findings: 
• Iliac disease was associated with younger age, cigarette 
smoking and male gender. 
• Infragenicular disease was associated with diabetes mellitus, 
older age, and male gender,  
• Hypercholesterolemia was less prevalent in patients with lesions 
below the knee. 
• hypertension was associated with no distinct pattern.  
 
Lack of standardized angiographic reporting schemes  particularly 
for infragenicular disease was a major problem in comparing 
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results from different researchers. Some authors suggested 
methods of categorising disease severity (8) as a way of trying to 
address this problem.  
Despite this, the dominant notion in the literature was that of 
diabetic patient having a severe involvement  of distal arterial 
segment than their non-diabetic counterparts. 
 
Arterial foot arch status in diabetic patients  
Recent studies investigated the impact of the quality of the 
arterial foot arch on various outcomes ranging for rate of wound 
healing rates, graft patency rates as well as amputation free 
survival(17)(18). The general impression is that the quality of the 
arterial foot arch has a positive impact on the wound healing rate  
but does not affect the graft patency rate or the amputation free 
survival (17)(18). Direct vs indirect pedal angiosome 
revascularization in patients with critical limb ischaemia  is an 
area of active research (19)(22)(23)(24)(26) 
(27)(28)(29)(30)(31). A recent meta-analysis and systematic 
review (2014) of nine studies concluded that when feasible direct  
foot angiosome revascularization may improve salvage and wound 
healing rates when compared with the indirect foot angiosome 
revascularization. . 
It remains a task of future research work to better model and 
design their studies in order to provide good evidence in 
answering these questions.  
 
Very little if any research work concerning this topics has been 
carried out  in Africa. 
 
Future perspective 
While admitting that it is impossible to completely avoiding 
confounding factors when addressing this topic, it is relevant to 
interrogate the nature of associations observed when stratifying 
patients according to patient-specific variables. It is the writer’s 
opinion that this approach would guide us in focusing resource 





13.  METHODS 
 
This is a one year prospective descriptive study (January 2014 to 
December 2014) carried out at Groote Schuur Hospital, Vascular 
Department. An informed consent was completed by the patient 
to be included in the study. (see appendix A : copy of consent 
form) 
 
13.1.  INCLUSIONS CRITERIA 
Included in this study are: 
 All diabetic patients ≥18 years of age with critical limb 
ischemia (Rutherford clinical category 4 – 6)  
 Patients who had pre and post-intervention vascular 
imaging.  
 
13.2.  METHOD OF DATA COLLECTION 
Data was collected into a Microsoft Access database which is 
password protected and stored on a dedicated computer. 
To ensure data consistency our database is designed with the 
following functionalities  
 Calendar date pickups  
 Drop down menus  with either multiple select or single 
select options  
 Fixed data types  
(See Appendix C for the database snapshot.) 
 
 
13.3.  PATENCY LEVEL RECORDING FOR AORTO-ILIAC TO 
TIBIOPERONEAL ARTERIAL SEGMENTS:  
 
All 12 main arteries on the symptomatic side from the infra-renal aorta 
to the crural arteries (Fig 1.01) had their patency levels graded and 
recorded using a very simple grading system (Fig 1.02). 
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Patency level Grading System for aorto-iliac to tibioperoneal 
arterial segments 
 
Category 1: Widely patent (Angiographic image  with clean 
pristine edges)  
Category 2: Diffusely diseased but patent (Shaggy edges but 
no obvious stenosis)  
Category 3: haemodynamically insignificant occlusive 
lesions (Areas with <50% stenosis) 
Category 4: Haemodynamically significant occlusive lesions 
(Areas with ≥ 50 % stenosis) 










13.4.  ARTERIAL FOOT ARCH CLASSIFICATION 
 
 
The arterial foot arch status was assessed on pre-interventional 
digital subtraction angiograms (DSA) and where feasible, post 
interventional DSA after the inflow into the arch has been 
improved. The arterial foot arch is formed when the lateral plantar 
artery runs  across the bases of the metatarsal bones and 
anastomosis with the dorsalis pedis artery through the deep plantar 
artery. 
 
The arch status was assessed as follows: 
 Complete: The anastomosis between the lateral plantar and the 
dorsalis pedis is intact filling the metatarsal and digital arteries.  
 Incomplete: The anastomosis between the two arteries is not 
observed. 
 Absent : No visualized foot arch.  
 
The findings of the  two variables ( patency level of arterial segments 
and the arterial foot arch status) were then  each stratified according 
to:  
1. Gender 
2. Age groups (<40 years; 40-54 years and ≥55 years) 
3. Risk factor combinations of patients: 
o Group1 = (DM, HPT, Dyslipidemia);  
o Group 2= (DM, HPT, dyslipidemia, exsmoker);  
o Group 3 = (DM, HPT, dyslipidemia, smoker).  
The above three risk combination groups formed the majority 
of our study group (79%). 
 
 
13.5.  STATISTICS  
The calculated minimum sample size of 63 limbs (756 patency levels 
(63x12))was needed to achieve a power of 86% to detect a difference 
of 0.1900 (19%) with a target significance level of 0.0500 (using PASS 
11 software). The equality of distribution of categories was analyzed 
using the One sample Chi-square test (SPSS 21) with our Null 
hypothesis (N0) assuming that categories occur with equal proportions. 
 
 
14.  RESULTS  
 
Seventy six  patients enrolled into this study and five were excluded 
from the study for not having any vascular imaging (poor candidates for 




 38/71 females  
 33/71 males.  
The age group composition:  
 Only one patient was younger than 40 years (female).  
 16 patients were 40-55 years.  
 54 (76%) patients were ≥ 55years.                                 
Risk factor profile: Three risk factor combinations dominated 
(comprising 79% of our patients): 
 Group 1 (DM, HPT, Dyslipidemia);  
 Group 2 (DM, HPT, dyslipidemia, ex-smoker)  
 Group 3 (HPT, dyslipidemia, smoking)  
The remaining 21% constituted variable risk factor combinations which 
were  too small to assign to a group for statistical analysis. 
 
14.1.  AORTO-ILIAC TO TIBIOPERONEAL SEGMENT PATENCY LEVEL 
ANALYSIS  
 
14.1.1.  Pattern and distribution of PAD in all diabetic patients   
 
Table 1.d  shows the  total number of patency categories recorded. 
There were 8 aorto-iliac segments which were not imaged which 
translates to 32 un-imaged aortoiliac arteries ( 4x8 = 32 arteries).  
Therefore the total number of  imaged arteries is (852-32 = 820). 
 
 
The distribution of this patency levels across the 12 arteries as 
well as the three arterial segments is shown on Table 1.e & 1.f 
and Fig 1.03 & 1.04. The Null hypothesis assumes that the 
distribution of each patency category  is equal across the 3 
arterial segments (aorto-iliac, femoropopliteal, and tibioperoneal 
segments). It is important to note that there are 4 arteries graded 
at each segment.  
 
It becomes evident on Fig 1.04 that the severity of disease 
increases from proximal arterial segments (aorto-iliac segment) to 
distal arterial segments (tibioperoneal segment). The reverse is 
true for the less severe patency categories  (category 1 & 2) 
showing that the proximal segments are more patent than distal 
segments. Category 3 is equally distributed (P =0.779, therefore  
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retaining the null hypothesis). The distal predominance of 
category 4 and 5 is statistically significant (P <0.001). The 
proximal predominance of category 1 and 2 is also statistically 
significant (P <0.001 and P = 0.05 respectively). Significance 
levels are shown in Table 1.c as asymptotic significance level of 
chi square test. 
 







14.1.2.  Age group stratified pattern and distribution of 
PAD   
Only one patient was younger than 40 years (Fig1.05). Table 1.g 
shows total number of all patency categories per age group.  
There are 12 patency categories recorded for  the one patient <40 
years age; 188 patency categories for 40-54 age group and 620 
patency categories  for ≥55 years age group (Table 1.g). Fig 1.06 
shows the distribution of this patency categories  across the 
arterial segments in a bar chart form. There are relatively more 
category 4 and 5 patency levels  found in the tibioperoneal 
segment. The statistical significance for this disproportionate 
distribution is P <0.001 & P = 0.003 respectively for ≥55 age 
group; P = 0.013 & P = 0.019 respectively for age group of 40-54 






















Fig 1.06 Age group stratified patency categories  
Table 1.h Age group stratified segment patency categories with significance 




14.1.3.  Gender stratified pattern and distribution of PAD 
38 females and 33 males were analyzed (Fig 1.07). Table 1.f 
shows all patency levels recorded for males and females, with 388 
grades recorded for males and 432 recorded for females. Table1.j 
and Fig 1.08 show the distribution of these patency levels across 
the three arterial segments. The frequency of category 5 and 
category 4 increase from proximal to distal segments with 
predominance in tibioperoneal segments (P <0.001 & p = 0.001 
respectively for females; P < 0.001 & P=0.026 respectively for 
males). Likewise the widely patent arteries (category 1) are 
predominantly found in the aorto-iliac segment (P <0.001 for both 
females and males). It is worth noting that though there are more 
females than males in this study, females had no category 5 
lesions in the aortoiliac segments compared to males who had 6 










14.1.4.  Risk factor stratified pattern and distribution of  
PAD 
Three risk factor combinations form the bulk of our patients 
Group 1(DM,HPT, Dyslipidemia); Group 2(DM,HPT, dyslipidemia, 
exsmoker) and Group 3(DM,HPT,dyslipidemia, smoker). These 
risk factor combinations account for 79%  of our patients (labelled 
common combinations in Fig 1.09). The remaining 21% is almost 
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equally divided amongst the other 4 risk factor combinations(Fig 
1.09).  
A total of 656 patency categories (115+60+42+354+85 = 656) 
were described for groups 1, 2 and 3 (Table 1.h) . Table 1.l shows 
the distribution of patency levels across the arterial segments for 
the three common risk factor combinations. Asymptotic 
significance levels (P value equivalence) are shown in table 1.l. 
Group 1 and group 2 displayed the classic observation of worse 
disease in the distal arterial segment (Fig 1.11). For these two 
risk factor combinations, category 5 lesions predominate the  
tibioperoneal segment (P<0.001 for both risk factor 
combinations). In contrast group 3 have significantly unequal 
distribution of category 5 (occlusions) patency levels (P<0.001) 
but with more occlusions in the femoropopliteal segment  than in 
the tibioperoneal segment. The rest of other grades of patency 
level in group 3 are almost equally distributed (P > 0.05).  
 
Fig 1.10 shows the 4 risk factor combination that constituted the 
minority of our patients as a frequency bar chart of patency levels 




















14.2.  ARTERIAL FOOT ARCH STATUS ANALYSIS: 
The arterial foot arch status was assessed on pre-interventional 
digital subtraction angiograms (DSA) and where feasible, post 
interventional DSA after the inflow into the arch has been 
improved. The arterial arch is formed when the lateral plantar 
artery runs  across the bases of the metatarsal bones and 
anastomosis with the dorsalis pedis artery through the deep 





The arch status was assessed as follows: 
 Complete: the anastomosis between the lateral plantar and 
the dorsalis pedis is intact filling the metatarsal and digital 
arteries  
 Incomplete: the anastomosis between the two arteries is 
not observed 
 Absent : No visualized foot arch   
 
14.2.1.  All diabetic patients: 
 
Fig 1.12 shows the frequency of arterial foot arch patency levels 
 
10 absent (occluded); 
28 incomplete;      
31  complete;  
  2poor imaging of the foot arch with lots of    motion  
artifacts (unclassified). 
 
Disproportionate distribution among the three arterial foot arch 
patency levels was significant (P = 0.004). Although the majority 
of patients had a complete arch, the difference between numbers 
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of patients with complete vs incomplete arch was only 3. On the 
other hand there were significantly fewer patients with absent foot 
arch (almost three times smaller than the other groups). 
14.2.2.  Gender stratification of arch status: On stratifying 
the above observation according to gender, it becomes clear that 
a good proportion of females {[22/38 (58%) females] vs [9/33 
(27%) males] } have a complete arch. Relatively fewer 
females{4/38(11%)} had absent arch vs {6/33(18%)} in males. 
The majority of males had an incomplete foot arch 
{17/33(58%)}. For both females and males there was 
disproportionate distribution between the categories of the arch 
status categories (P = 0.004 females and P = 0.048 males )Table 
1.m. Therefore this disproportionate distribution cannot be 











14.2.3.  Age group stratified arch status: Most of our patients 
were ≥55years of age and their distribution among the arch 
status categories was significantly disproportionate (P = 0.028) 
with more patients having complete foot arches (23/54) followed 
by incomplete foot arches (21/54). Only 8/54 patients in these 
age group had an absent arterial foot arch. There were 16 
patients in the 40-54 years age group. Only 2/16  had absent foot 
arches and the remaining (14) were equally divided between the 
complete and incomplete foot arch categories. Only one patient 




14.2.4.  Risk factor profile stratified arch status  
Three risk factor combinations dominated. 79% of our patients 
belonged to one of the following risk factor profiles:  
1. DM, HPT, Dyslipidemia (Group 1) 
2. DM, HPT, Dyslipidemia, Exsmoker (Group 2) 
3. DM, HPT, Dyslipidemia, Smoker (Group 3) 
 
 
Group 2(DM, HPT, Dyslipidemia, Ex-smoker) had predominantly 
complete foot arches 9/13 . The remaining 4 patients were equally 
distributed between incomplete and absent foot arches. For Group 
3 (DM, HPT, Dyslipidemia, Smoker) and Group 1(DM, HPT, 
Dyslipidemia) proportions in each foot arch status category were 
almost the same with slight predominance of incomplete foot 
arch, followed by complete foot arch as shown in the Table 1.n 
and Figure 1.16.  These unequal distribution within the risk factor 








15.  DISCUSSION 
Research  work concerning this topic took off in the 1980s (1) (2) 
with the advent of DSA. A number of studies supported the notion 
that diabetic patients with peripheral artery occlusive disease 
have severe involvement of tibioperoneal segment  (1) (2) (11) 
(5) (10) (8)and relative sparing of the arterial foot arch (1). 
However some studies disagreed with this notion of severe distal 
arterial segment involvement in diabetic patients (3) and the 
arterial foot arch sparing (3) (2).  
 
Understanding the variability of pattern and distributions of PAD 
according to risk factor profile, gender and age group would add 
further to our understanding of these observations.  
 
15.1. Our study highlighted key findings which are worth 
mentioning: 
 
In general we found that diabetic patients have severe distal 
arterial segment involvement. Female diabetic patients have 
relatively less severe disease. Group 3 (DM 
,HPT,Dyslipidemia,Smoker) have a more severe involvement 
of the femoropopliteal arterial segment. This risk factor 
combination difference seems to explain the isolated peak in 
severe patency levels of SFA (occlusions and high grade 
occlusive disease ) in Fig 1.03  when analyzing the 
distribution of patency levels artery by artery. Interestingly, 
a group with same risk factor combinations except that they 
were exsmoker –group 3(DM,HPT, Dyslipidemia, Exsmoker)- 
have less affliction of  femoropopliteal segment. This seems 
to suggest that smoking increases the severity of arterial 
occlusive disease in the femoropopliteal segment or 
proximal segments. A study by N. Diehm, A. S.-D. (2006) 
(11) found  that smoking had a higher relative risk ratio for 
severe affliction of the aorto-iliac segment. 
In analysing  the arterial foot arch status it turned out that 
female diabetic patients had significant relative arterial foot 
arch sparing while their male counterparts had a largely 
incomplete foot arch. A difficult question to answer would be 
what is it about females that protects them from more 





15.2.  Shortcomings in our study: 
We could not make statistically significant conclusions in all 
age group stratification analyses mainly because we we 
lacked numbers in the younger age groups. The same 
problem arose  when analysing risk factor profile 
stratification  
variables. A common problem highlighted in previous similar 
studies (8) is lack of a standardised reporting criteria for the 
infragenicular arterial lesions and foot arch assessment. This 
is a real problem particularly when trying to compare results 
during a literature review or when doing a retrospective 
study on reported infragenicular vascular imaging. 
 
Future research perspectives: 
Extending the period of study to beyond a year may help 
accumulate more patients to represent the less common 
categories like younger patients with critical limb ischaemia 
and rare risk factor combinations. Another option would be 
to run a multicenter study to gain more numbers to make 

















16.  CONCLUSION 
 
Diabetic patients in general have severe tibio-peroneal disease 
.This finding was consistent in both genders , in all patients aged 
40 years and older and in Group 1(DM, HPT, Dyslipidemia) 
(P<0.001) and group 2(DM, HPT, dyslipidemia, exsmoker) 
(P<0.001). Group 3(HPT, dyslipidemia, smoker) have a different 
distribution pattern, with more occlusions in the femoropopliteal 
segment (P<0.001)  followed by tibioperoneal segment. This 
seems to suggest that smoking increases the severity of arterial 
occlusive disease in proximal segment.  
Female diabetics tends to have a complete arterial foot arch 
(P=0.004) as opposed to male patients who have predominantly 
incomplete arch (P=0.048). The Group 2 patients have 
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